These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103 [TBL] [Abstract][Full Text] [Related]
3. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224 [TBL] [Abstract][Full Text] [Related]
4. Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies. Woodle ES; Cronin D; Newell KA; Millis JM; Bruce DS; Piper JB; Haas M; Josephson MA; Thistlethwaite JR Transplantation; 1996 Oct; 62(7):906-10. PubMed ID: 8878382 [TBL] [Abstract][Full Text] [Related]
5. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351 [TBL] [Abstract][Full Text] [Related]
6. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Mayer AD; Dmitrewski J; Squifflet JP; Besse T; Grabensee B; Klein B; Eigler FW; Heemann U; Pichlmayr R; Behrend M; Vanrenterghem Y; Donck J; van Hooff J; Christiaans M; Morales JM; Andres A; Johnson RW; Short C; Buchholz B; Rehmert N; Land W; Schleibner S; Forsythe JL; Talbot D; Pohanka E Transplantation; 1997 Aug; 64(3):436-43. PubMed ID: 9275110 [TBL] [Abstract][Full Text] [Related]
7. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. Solez K; Vincenti F; Filo RS Transplantation; 1998 Dec; 66(12):1736-40. PubMed ID: 9884269 [TBL] [Abstract][Full Text] [Related]
8. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
12. Tacrolimus rescue in liver transplant patients with refractory rejection or intolerance or malabsorption of cyclosporine. The US Multicenter FK506 Liver Study Group. Klein A Liver Transpl Surg; 1999 Nov; 5(6):502-8. PubMed ID: 10545538 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients. Onsager DR; Canver CC; Jahania MS; Welter D; Michalski M; Hoffman AM; Mentzer RM; Love RB J Heart Lung Transplant; 1999 May; 18(5):448-55. PubMed ID: 10363689 [TBL] [Abstract][Full Text] [Related]
14. OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejection. Patschan D; Kribben A; Pietruck F; Lutz J; Binek M; Philipp T; Heemann U; Witzke O Nephron Clin Pract; 2006; 103(3):c94-9. PubMed ID: 16534238 [TBL] [Abstract][Full Text] [Related]
15. Tacrolimus rescue therapy for renal allograft rejection--five-year experience. Jordan ML; Naraghi R; Shapiro R; Smith D; Vivas CA; Scantlebury VP; Gritsch HA; McCauley J; Randhawa P; Demetris AJ; McMichael J; Fung JJ; Starzl TE Transplantation; 1997 Jan; 63(2):223-8. PubMed ID: 9020321 [TBL] [Abstract][Full Text] [Related]